Benzinga's Top Initiations By: Benzinga via Benzinga January 19, 2016 at 09:55 AM EST Analysts at Barclays initiated coverage on Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) with a Underweight rating. The target price for ... Read More >> Related Stocks: Adamas Pharma Horizon Therapeutics Ituran Location Novocure Ltd Ord Sh Pure Storage Inc